VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20050782 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20050620 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20050313 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20042338 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20050220 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20034643 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20043201 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS20066251 | HPV | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS44030311 | HTLV-1 | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
TVIS44026751 | HTLV-1 | ENSG00000139144.11 | protein_coding | PIK3C2G | No | No | 5288 | B7ZLY6 F5H369 O75747 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | PIK3C2G |
---|---|
DrugBank ID | DB12010 |
Drug Name | Fostamatinib |
Target ID | BE0009515 |
UniProt ID | O75747 |
Regulation Type | inhibitor |
PubMed IDs | 26516587 |
Citations | Rolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4. |
Groups | Approved; Investigational |
Direct Classification | Methoxyanilines |
SMILES | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL2103830 |